Effects of a Novel Infant Formula on Weight Gain, Body Composition, Safety and Tolerability to Infants: The INNOVA 2020 Study.

ABSTRACT: Exclusive breastfeeding is recommended for the first six months of life to promote adequate infant growth and development, and to reduce infant morbidity and mortality. However, whenever some mothers are not able to breastfeed their infants, infant formulas mimicking human milk are needed, and the safety and efficacy of each formula should be tested. Here, we report the results of a multicenter, randomized, blinded, controlled clinical trial that aimed to evaluate a novel starting formula on weight gain and body composition of infants up to 6 and 12 months, as well as safety and tolerability. For the intervention period, infants were divided into three groups: group 1 received formula 1 (Nutribén^® Innova 1 (Alter Farmacia S.A., Madrid, Spain) or INN (n = 70)), with a lowe

SUBMITTER: Plaza-Diaz J 

PROVIDER: S-EPMC9823847 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature